BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 18, Issue 1
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11060)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.
Item 
Count 
PDF741
HTML9575
Figures (1-3)384
Tables (1-3)360
 Sum=11060
Jan 7, 2012 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012; 18(1): 1-15 [PMID: 22228965 DOI: 10.3748/wjg.v18.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v18/i1/1.htm
Number Citing Articles
1
Andrea A. Gossard, Gregory J. Gores. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2017; 21(4): 725 doi: 10.1016/j.cld.2017.06.004
2
Andres F. Carrion, Kalyan Ram Bhamidimarri. Liver Transplant for Cholestatic Liver Diseases. Clinics in Liver Disease 2013; 17(2): 345 doi: 10.1016/j.cld.2012.12.005
3
Yujie Zhang, Xinbao Gao, Zhiyi He, Hui Jia, Min Chen, Xuan Wang, Liu Hong, Yuanyuan Cui, Jian Wan. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2022; 42(8): 1814 doi: 10.1111/liv.15339
4
T. H. Karlsen, M. Vesterhus, K. M. Boberg. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2014; 39(3): 282 doi: 10.1111/apt.12581
5
Won Kim. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. 2022; : 209 doi: 10.1007/978-981-19-0120-1_14
6
Siddharth Singh, Jayant A. Talwalkar. Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management. Clinical Gastroenterology and Hepatology 2013; 11(8): 898 doi: 10.1016/j.cgh.2013.02.016
7
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scandinavian Journal of Gastroenterology 2018; 53(3): 297 doi: 10.1080/00365521.2017.1421705
8
Francesco Paolo Russo, Alberto Zanetto. Textbook of Liver Transplantation. 2022; : 389 doi: 10.1007/978-3-030-82930-8_22
9
Fanni Gelley, Gergely Zádori, Dénes Görög, László Kóbori, Imre Fehérvári, György Gámán, Zsuzsanna Gerlei, Péter Nagy, Enikő Sárváry, Balázs Nemes. Recurrence of primary sclerosing cholangitis after liver transplantation — The Hungarian experience. Interventional Medicine and Applied Science 2014; 6(1): 16 doi: 10.1556/imas.6.2014.1.2
10
Yang Shi, Shuqun Hu, Qingwei Song, Shengcai Yu, Xiaojun Zhou, Jun Yin, Lei Qin, Haixin Qian. Gene Silencing of 4-1BB by RNA Interference Inhibits Acute Rejection in Rats with Liver Transplantation. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/192738
11
Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti. Main factors influencing long-term outcomes of liver transplantation in 2022. World Journal of Hepatology 2023; 15(3): 321-352 doi: 10.4254/wjh.v15.i3.321
12
Peder Rustøen Braadland, Annika Bergquist, Martin Kummen, Lars Bossen, Lise Katrine Engesæter, Henrik Mikael Reims, Ida Björk, Krzysztof Grzyb, Andreas Abildgaard, Milada Cvancarova Småstuen, Trine Folseraas, Marius Trøseid, Arve Ulvik, Per Magne Ueland, Espen Melum, Pål-Dag Line, Marte Lie Høivik, Henning Grønbæk, Tom Hemming Karlsen, Mette Vesterhus, Johannes Roksund Hov. Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. Journal of Hepatology 2023; 79(4): 955 doi: 10.1016/j.jhep.2023.05.038
13
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
14
A. J. Montano-Loza, R. A. Bhanji, S. Wasilenko, A. L. Mason. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Alimentary Pharmacology & Therapeutics 2017; 45(4): 485 doi: 10.1111/apt.13894
15
Christina W. Lee, Sean Ronnekleiv-Kelly. Autoimmune Diseases of the Biliary Tract. Surgical Clinics of North America 2019; 99(2): 185 doi: 10.1016/j.suc.2018.11.003
16
Claire Durkin, Therese Bittermann. Liver transplantation for alcohol-associated hepatitis. Current Opinion in Organ Transplantation 2022;  doi: 10.1097/MOT.0000000000001044
17
EASL Clinical Practice Guidelines: Liver transplantation. Journal of Hepatology 2016; 64(2): 433 doi: 10.1016/j.jhep.2015.10.006
18
Nora V. Bergasa. Clinical Cases in Hepatology. 2022; : 123 doi: 10.1007/978-1-4471-4715-2_5
19
Ivo W. Graziadei. Recurrence of Nonviral Liver Diseases After Liver Transplantation. Clinics in Liver Disease 2014; 18(3): 675 doi: 10.1016/j.cld.2014.05.009
20
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal 2019; : 101 doi: 10.33590/emj/10313809
21
Mikio Zeniya, Masaki Iwai, Arief A. Suriawinata. Diagnosis of Liver Disease. 2019; : 97 doi: 10.1007/978-981-13-6806-6_9
22
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
23
Denise M. Harnois, Kymberly D. S. Watt. Cholestatic Liver Disease. Clinical Gastroenterology 2014; : 189 doi: 10.1007/978-1-4939-1013-7_10
24
Johannes Klose, Michelle A. Klose, Courtney Metz, Frank Lehner, Michael P. Manns, Juergen Klempnauer, Nils Hoppe, Harald Schrem, Alexander Kaltenborn. Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbeck's Archives of Surgery 2014; 399(8): 1021 doi: 10.1007/s00423-014-1214-6
25
Ken Liu, Simone I. Strasser, David J. Koorey, Rupert W. Leong, Michael Solomon, Geoffrey W. McCaughan. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 949 doi: 10.1080/17474124.2017.1343666
26
Marianna Maspero, Stefan D. Holubar, Roma Raj, Sumeyye Yilmaz, Christopher Prien, Olga Lavryk, Alejandro Pita, Koji Hashimoto, Scott R. Steele, Tracy L. Hull. Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease (PSC-IBD). Annals of Surgery 2023;  doi: 10.1097/SLA.0000000000006041
27
Aditi Kumar, Daniel Wheatley, Amar Puttanna. Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management. Clinical Medicine Insights: Gastroenterology 2016; 9: CGast.S38451 doi: 10.4137/CGast.S38451
28
Ertan Emek, Ayfer Serin, Tolga Sahin, Pinar Yazici, Yildiray Yuzer, Yaman Tokat, Birkan Bozkurt. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience. Transplantation Proceedings 2019; 51(7): 2439 doi: 10.1016/j.transproceed.2019.01.156
29
Hannah R. Hrncir, Fransky Hantelys, Adam D. Gracz. Panic at the Bile Duct. The American Journal of Pathology 2023; 193(10): 1440 doi: 10.1016/j.ajpath.2023.02.012
30
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderon-Martinez, Angad Tiwari, SriLakshmiDevi Kanumilli, Purva Shah, Bhanu Siva Mohan Pinnam, Hassam Ali, Dushyant Singh Dahiya. Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 2023; 15(8): 939-953 doi: 10.4254/wjh.v15.i8.939
31
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2017; : 355 doi: 10.1007/978-3-319-07209-8_21
32
David Uihwan Lee, Samantha Menegas, Ki Jung Lee, Alex Pu, Kuntal Bhowmick, Reid Ponder, Gregory Hongyuan Fan, Harrison Chou, KeeSeok Lee, Nathalie H. Urrunaga. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 2023; 68(9): 3781 doi: 10.1007/s10620-023-08023-y
33
Rachita Khot, Matthew A. Morgan, Rashmi T. Nair, Daniel R. Ludwig, Hina Arif-Tiwari, Chandra S. Bhati, Malak Itani. Radiologic findings of biliary complications post liver transplantation. Abdominal Radiology 2022; 48(1): 166 doi: 10.1007/s00261-022-03714-y
34
Nathalie A. Pena Polanco, Cynthia Levy, Eric F. Martin. Cholestatic Liver Diseases After Liver Transplant. Clinics in Liver Disease 2017; 21(2): 403 doi: 10.1016/j.cld.2016.12.011
35
Michael R. Lucey, Norah Terrault, Lolu Ojo, Eileen J. Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transplantation 2013; 19(1): 3 doi: 10.1002/lt.23566
36
Olalekan Lee Aiyegbusi, Fatima Isa, Derek Kyte, Tanya Pankhurst, Larissa Kerecuk, James Ferguson, Graham Lipkin, Melanie Calvert. Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study. Health and Quality of Life Outcomes 2020; 18(1) doi: 10.1186/s12955-020-01438-5
37
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2): 659 doi: 10.1002/hep.32771
38
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin 2015; 114(1): 53 doi: 10.1093/bmb/ldv019
39
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases. 2014; : 925 doi: 10.1016/B978-0-12-384929-8.00063-0
40
Bijan Eghtesad, John J. Fung. Pouchitis and Ileal Pouch Disorders. 2019; : 487 doi: 10.1016/B978-0-12-809402-0.00039-3
41
Christina Villard, Ingalill Friis-Liby, Fredrik Rorsman, Karouk Said, Anna Warnqvist, Martin Cornillet, Stergios Kechagias, Nils Nyhlin, Mårten Werner, Izabella Janczewska, Therese Hagström, Emma Nilsson, Annika Bergquist. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. Journal of Hepatology 2023; 78(3): 604 doi: 10.1016/j.jhep.2022.11.011
42
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
43
Mary Ayers, Silvia Liu, Aatur D. Singhi, Karis Kosar, Pamela Cornuet, Kari Nejak-Bowen. Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-04358-6
44
Wenyi Chen, Jiaqi Zhu, Feiyan Lin, Yanping Xu, Bing Feng, Xudong Feng, Xinyu Sheng, Xiaowei Shi, Qiaoling Pan, Jinfeng Yang, Jiong Yu, Lanjuan Li, Hongcui Cao. Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02271-3
45
Frank Schmitz. MR-Cholangiographie bringt Licht ins Dunkel der PSC bei chronisch-entzündlicher Darmerkrankung. Der Gastroenterologe 2016; 11(6): 495 doi: 10.1007/s11377-016-0119-z
46
Siddharth Singh, Edward V Loftus, Jayant A Talwalkar. Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2013; 108(9): 1417 doi: 10.1038/ajg.2013.163
47
Chaoran Zhang, Trana Hussaini, Eric M Yoshida. Review of pharmacotherapeutic treatments for primary sclerosing cholangitis. Canadian Liver Journal 2019; 2(3): 58 doi: 10.3138/canlivj-2018-0016
48
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 2020; 33(3): 251 doi: 10.17533/udea.iatreia.57
49
Lydia M. Petrovic. Recurrent diseases following liver transplantation. Current Opinion in Organ Transplantation 2012; 17(3): 293 doi: 10.1097/MOT.0b013e32835365f6
50
Christopher L. Welle, Patrick J. Navin, Michael C. Olson, Safa Hoodeshenas, Michael S. Torbenson, Sudhakar K. Venkatesh. MR elastography in primary sclerosing cholangitis: a pictorial review. Abdominal Radiology 2022; 48(1): 63 doi: 10.1007/s00261-022-03529-x
51
Veena L Venkat, Sarangarajan Ranganathan, Rakesh Sindhi. The challenges of liver transplantation in children with primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2015; 9(3): 289 doi: 10.1586/17474124.2015.1002085
52
Mohamad A. Mouchli, Mohamed K. Osman, Bradley Busebee, Timucin Taner, Julie K. Heimbach, John Eaton, Omar Mousa, Kristin Cole, Kymberly D. Watt. Long-term (15 y) complications and outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transplantation 2024;  doi: 10.1097/LVT.0000000000000523
53
Palak J. Trivedi, Irene Scalera, Emma Slaney, Richard W. Laing, Bridget Gunson, Gideon M. Hirschfield, Andrea Schlegel, James Ferguson, Paolo Muiesan. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. Journal of Hepatology 2017; 67(5): 957 doi: 10.1016/j.jhep.2017.06.027
54
Varun Saxena, Norah A. Terrault. Zakim and Boyer's Hepatology. 2018; : 784 doi: 10.1016/B978-0-323-37591-7.00053-7
55
Trygve Thorsen, Einar Martin Aandahl, William Bennet, Michael Olausson, Bo-Göran Ericzon, Greg Nowak, Frans Duraj, Helena Isoniemi, Allan Rasmussen, Tom H. Karlsen, Aksel Foss. Transplantation With Livers From Deceased Donors Older Than 75 Years. Transplantation 2015; 99(12): 2534 doi: 10.1097/TP.0000000000000728
56
Jonathan Merola, Robert M. Mocharla, Alexander Z. Jow, Samuel H. Sigal, Amar Safdar. Principles and Practice of Transplant Infectious Diseases. 2019; : 303 doi: 10.1007/978-1-4939-9034-4_17
57
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4): 965 doi: 10.1097/HEP.0000000000000506
58
Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner. Liver Immunology. 2014; : 301 doi: 10.1007/978-3-319-02096-9_20
59
Sanjaya K. Satapathy, Ollie D. Jones, Jason M. Vanatta, Faisal Kamal, Satish K. Kedia, Yu Jiang, Satheesh P. Nair, James D. Eason. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid. Transplantation Direct 2017; 3(7): e178 doi: 10.1097/TXD.0000000000000693
60
Brian K. Chung, Tom Hemming Karlsen, Trine Folseraas. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1390 doi: 10.1016/j.bbadis.2017.08.020
61
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; : 129 doi: 10.1007/978-3-031-14744-9_11
62
Michael R. Lucey. Liver Transplantation. 2013; : 290 doi: 10.1002/9781118675915.ch26
63
Marianna Maspero, Koji Hashimoto, Robert L. Fairchild, Andrea Schlegel. Reply: Acute rejection after transplantation of machine perfused livers—We have barely scratched the surface. Hepatology 2023; 78(4): E69 doi: 10.1097/HEP.0000000000000483
64
Julie R. Ingelfinger, Konstantinos N. Lazaridis, Nicholas F. LaRusso. Primary Sclerosing Cholangitis. New England Journal of Medicine 2016; 375(12): 1161 doi: 10.1056/NEJMra1506330
65
John E. Eaton, Jayant A. Talwalkar, Konstantinos N. Lazaridis, Gregory J. Gores, Keith D. Lindor. Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management. Gastroenterology 2013; 145(3): 521 doi: 10.1053/j.gastro.2013.06.052
66
Shishir Shetty, David H Adams, Stefan G Hubscher. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2012; 8(7): 645 doi: 10.1586/eci.12.65
67
Sally Condon, Cynthia Levy, Eric F. Martin. Recurrent and De Novo Liver Disease After Liver Transplantation. Clinics in Liver Disease 2025;  doi: 10.1016/j.cld.2024.12.008
68
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Seminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
69
Ivo Graziadei. Lebertransplantation. Wiener klinische Wochenschrift Education 2013; 8(2): 43 doi: 10.1007/s11812-013-0059-1
70
Michael Huw Chapman, Douglas Thorburn, Gideon M Hirschfield, George G J Webster, Simon M Rushbrook, Graeme Alexander, Jane Collier, Jessica K Dyson, David EJ Jones, Imran Patanwala, Collette Thain, Martine Walmsley, Stephen P Pereira. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 2019; 68(8): 1356 doi: 10.1136/gutjnl-2018-317993
71
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi. Transplantation of the Liver. 2015; : 1112 doi: 10.1016/B978-1-4557-0268-8.00084-1
72
Tatiana Hildebrand, Nadine Pannicke, Alexander Dechene, Daniel N. Gotthardt, Gabriele Kirchner, Florian P. Reiter, Martina Sterneck, Kerstin Herzer, Henrike Lenzen, Christian Rupp, Hannelore Barg‐Hock, Philipp de Leuw, Andreas Teufel, Vincent Zimmer, Frank Lammert, Christoph Sarrazin, Ulrich Spengler, Christian Rust, Michael P. Manns, Christian P. Strassburg, Christoph Schramm, Tobias J. Weismüller. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis. Liver Transplantation 2016; 22(1): 42 doi: 10.1002/lt.24350
73
Tanja Schoknecht, Dorothee Schwinge, Stephanie Stein, Christina Weiler-Normann, Marcial Sebode, Sören Mucha, Benjamin Otto, Eva Ellinghaus, Felix Stahl, Andre Franke, Ansgar W Lohse, Johannes Herkel, Christoph Schramm. CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. Journal of Leukocyte Biology 2017; 101(2): 589 doi: 10.1189/jlb.5A1015-469R
74
Nobuhisa Akamatsu, Kiyoshi Hasegawa, Hiroto Egawa, Hideki Ohdan, Atsushi Yoshizawa, Norihiro Kokudo, Susumu Tazuma, Atsushi Tanaka, Hajime Takikawa. Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study. Transplant International 2021; 34(5): 916 doi: 10.1111/tri.13852
75
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
76
Christopher L. Bowlus. The Rose and Mackay Textbook of Autoimmune Diseases. 2024; : 845 doi: 10.1016/B978-0-443-23947-2.00020-5
77
Wenzel Schöning, Maximilian Schmeding, Florian Ulmer, Anne Andert, Ulf Neumann. Liver Transplantation for Patients with Cholestatic Liver Diseases. Visceral Medicine 2015; 31(3): 194 doi: 10.1159/000431017
78
Ming-Li Yin, Hong-Li Song, Yang Yang, Wei-Ping Zheng, Tao Liu, Zhong-Yang Shen. Effect of <i>CXCR3/HO-1</i> genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection. World Journal of Gastroenterology 2017; 23(22): 4016-4038 doi: 10.3748/wjg.v23.i22.4016
79
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
80
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 2022; 5: 100065 doi: 10.1016/j.hsr.2022.100065
81
Wajeeh Salah, M. Edwyn Harrison. Practical Gastroenterology and Hepatology Board Review Toolkit. 2016; : 543 doi: 10.1002/9781119127437.ch86
82
N Simonian, M Brahmania, M Bhat, A Kim, HLA Janssen, BE Hansen, K Patel. Predictors of early and long-term readmissions and their association with survival after liver transplantation. Journal of Liver Transplantation 2024; 13: 100195 doi: 10.1016/j.liver.2023.100195
83
Kate D. Williamson, Roger W. Chapman. Primary Sclerosing Cholangitis. Digestive Diseases 2014; 32(4): 438 doi: 10.1159/000358150
84
Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, Emmanuel Tsochatzis, Evangelos Thalassinos, Tu Vinh Luong, Nancy Rolando, Amar Paul Dhillon, David Patch, James O’Beirne, Douglas Thorburn, Andrew Kenneth Burroughs. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome. Journal of Hepatology 2013; 58(2): 262 doi: 10.1016/j.jhep.2012.09.019
85
Ahmad Anouti, Madhukar S. Patel, Lisa B. VanWagner, William M. Lee, John J. Fung, George Cholankeril, Christine S. Hwang, Arjmand R. Mufti, Shannan Tujios, Thomas Kerr, Nicole E. Rich, Jeremy Louissaint, Dev M. Desai, Parsia A. Vagefi, Steven Hanish, Jigesh Shah, Amit G. Singal, Thomas G. Cotter. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver International 2023; 43(10): 2198 doi: 10.1111/liv.15689
86
Elisa Catanzaro, Enrico Gringeri, Nora Cazzagon, Annarosa Floreani, Umberto Cillo, Patrizia Burra, Martina Gambato. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. Journal of Personalized Medicine 2024; 14(3): 222 doi: 10.3390/jpm14030222
87
R.W. Chapman, K.D. Williamson. The Digestive Involvement in Systemic Autoimmune Diseases. Handbook of Systemic Autoimmune Diseases 2017; 13: 119 doi: 10.1016/B978-0-444-63707-9.00007-6
88
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(2): 350 doi: 10.1016/j.jceh.2022.07.002
89
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 2015; 50(6): 781 doi: 10.3109/00365521.2015.1028996
90
Mette Vesterhus, Tom Hemming Karlsen. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. Journal of Gastroenterology 2020; 55(6): 588 doi: 10.1007/s00535-020-01681-z
91
Konstantinos N. Lazaridis, Nicholas F. LaRusso. The Cholangiopathies. Mayo Clinic Proceedings 2015; 90(6): 791 doi: 10.1016/j.mayocp.2015.03.017
92
Neelam G Gidwaney, Swati Pawa, Kiron M Das. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World Journal of Gastroenterology 2017; 23(14): 2459-2469 doi: 10.3748/wjg.v23.i14.2459
93
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
94
Lauren A. Beste, Anne M. Larson. Primary Care of the Solid Organ Transplant Recipient. 2020; : 77 doi: 10.1007/978-3-030-50629-2_5
95
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitis. The Lancet 2018; 391(10139): 2547 doi: 10.1016/S0140-6736(18)30300-3
96
Andrew L. Mason, Aldo J. Montano-Loza. Systematic Investigation of Elevated Cholestatic Enzymes During The Third Posttransplant Month. Liver Transplantation 2013; 19(Suppl. 2): S23 doi: 10.1002/lt.23742
97
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Nazia Selzner, Christopher Bredeson, David Grant, Oyedele Adeyi, Sandra Fischer, Anthony J. Demetris, Jianhua Zhang, Maor Epstein, Meaghan Macarthur, Anne Marie Clement, Korosh Khalili, David Allan, Sultan Altouri, Isabelle Bence-Bruckler, Mark Cattral, Jill Fulcher, Zita Galvin, Anand Ghanekar, Paul Greig, Lothar Huebsch, Atul Humar, Andrea Kew, Natasha Kekre, Tae Kyoung Kim, Sheryl McDiarmid, Lisa Martin, Ian McGilvray, Mitchell Sabloff, Gonzalo Sapisochin, Markus Selzner, Robert Smith, Kathryn Tinckam, Tae Joon Yi, Gary Levy, Harold Atkins. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study. Transplantation 2022; 106(3): 562 doi: 10.1097/TP.0000000000003829
98
Murat Harputluoglu, Mehmet Zeki Calgin, Engin Ataman, Deniz Tikici, Koray Kutluturk, Ramazan Kutlu, Cumali Savas Efe, Sezai Yilmaz. Outcomes of patients with primary sclerosing cholangitis after liver transplantation in a predominantly living donor liver transplant center. Journal of Liver Transplantation 2023; 12: 100186 doi: 10.1016/j.liver.2023.100186
99
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani, Fardad Ejtehadi. Cholangiocarcinoma and liver transplantation: What we know so far?. World Journal of Gastrointestinal Pathophysiology 2021; 12(5): 84-105 doi: 10.4291/wjgp.v12.i5.84
100
Lukas Bajer, Antonij Slavcev, Peter Macinga, Eva Sticova, Jan Brezina, Matej Roder, Radim Janousek, Pavel Trunecka, Julius Spicak, Pavel Drastich. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with <i>de novo</i> inflammatory bowel disease. World Journal of Gastroenterology 2018; 24(43): 4939-4949 doi: 10.3748/wjg.v24.i43.4939
101
Adam VanHuis, Veronica Loy. Myth: Liver Transplant Provides a Cure for Liver Disease. Clinical Liver Disease 2019; 13(6): 154 doi: 10.1002/cld.770
102
René P. Michel, Victoria A. Marcus. Pathology of Transplantation. 2016; : 173 doi: 10.1007/978-3-319-29683-8_6
103
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System. 2018; : 341 doi: 10.1002/9781119237662.ch18
104
Yan-Hua Lai, Wei-Dong Duan, Qiang Yu, Sheng Ye, Nian-Jun Xiao, Dong-Xin Zhang, Zhi-Qiang Huang, Zhan-Yu Yang, Jia-Hong Dong. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. World Journal of Gastroenterology 2015; 21(20): 6296-6303 doi: 10.3748/wjg.v21.i20.6296
105
Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo, Benjamin M. Yeh. Imaging of autoimmune biliary disease. Abdominal Radiology 2017; 42(1): 3 doi: 10.1007/s00261-016-0903-8
106
Dorothee Schwinge, Christoph Schramm. Sex-related factors in autoimmune liver diseases. Seminars in Immunopathology 2019; 41(2): 165 doi: 10.1007/s00281-018-0715-8
107
Keith D Lindor, Kris V Kowdley, Edwyn M Harrison. ACG Clinical Guideline: Primary Sclerosing Cholangitis. American Journal of Gastroenterology 2015; 110(5): 646 doi: 10.1038/ajg.2015.112
108
Non-Neoplastic Diseases of the Liver. 2022; : 353 doi: 10.55418/9781933477183-11
109
Tom H. Karlsen, Kirsten Muri Boberg. Update on primary sclerosing cholangitis. Journal of Hepatology 2013; 59(3): 571 doi: 10.1016/j.jhep.2013.03.015
110
Monica Tincopa. CAQ Corner: Long‐term medical complications of liver transplantation. Liver Transplantation 2023; 29(5): 548 doi: 10.1002/lt.26486
111
Cynthia Levy, Stephen Caldwell, Parvez Mantry, Velimir Luketic, Charles S. Landis, Jonathan Huang, Edward Mena, Rahul Maheshwari, Kevin Rank, Jun Xu, Vladislav A. Malkov, Andrew N. Billin, Xiangyu Liu, Xiaomin Lu, William T. Barchuk, Timothy R. Watkins, Chuhan Chung, Robert P. Myers, Kris V. Kowdley. Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study. Clinical and Translational Gastroenterology 2024; 15(8): e00744 doi: 10.14309/ctg.0000000000000744
112
Gary C. Kanel. Atlas of Liver Pathology. 2024; : 445 doi: 10.1016/B978-0-323-82533-7.00013-2
113
David Choi, Mengyuan Liu, Dharani Guttikonda, Kelly Galen, Grace Guzman, Hoonbae Jeon, Costica Aloman. Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective study. Transplant International 2020; 33(12): 1779 doi: 10.1111/tri.13756
114
Nabiha Faisal, Eberhard L Renner. Recurrence of autoimmune liver diseases after liver transplantation. World Journal of Hepatology 2015; 7(29): 2896-2905 doi: 10.4254/wjh.v7.i29.2896
115
Michael E. Sutton, Rico D. Bense, Ton Lisman, Eric J. van der Jagt, Aad P. van den Berg, Robert J. Porte. Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy. Liver Transplantation 2014; 20(4): 457 doi: 10.1002/lt.23827
116
Xiaoying Liu, Sarah A. Taylor, Stela Celaj, Josh Levitsky, Richard M. Green. Expression of unfolded protein response genes in post-transplantation liver biopsies. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02459-8
117
Christopher L. Bowlus. Liver Immunology. 2020; : 395 doi: 10.1007/978-3-030-51709-0_25
118
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345